Stephens Investment Management Group LLC
Source: SEC Form 13F · as of Mar 2026Stephens Investment Management Group LLC holds 10 biotech & pharma companies tracked by BioSniper, totaling $710.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
10
Total value held
$710.9M
| Company | Shares | Value |
|---|---|---|
| LGNDLigand Pharmaceuticals Incorporated | 494,670 | $98.8M |
| RGENREPLIGEN CORP | 755,571 | $89.0M |
| HALOHALOZYME THERAPEUTICS, INC. | 1,218,668 | $78.8M |
| MEDPMedpace Holdings Inc. | 162,797 | $78.2M |
| SUPNSUPERNUS PHARMACEUTICALS, INC. | 1,351,331 | $69.9M |
| ICLRICON plc | 599,176 | $66.3M |
| GMEDGlobus Medical Inc. | 714,701 | $61.6M |
| TECHBIO-TECHNE Corp | 1,104,057 | $57.7M |
| IDXXIDEXX LABORATORIES INC /DE | 102,097 | $57.4M |
| TVTXTravere Therapeutics, Inc. | 1,798,466 | $53.4M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.